Starship Children's Health is a public children's hospital in Auckland, New Zealand. Opened on 18 November 1991, it was one of the first purpose-built children's hospitals in New Zealand, and is the largest such facility in the country.

There are 219 beds in Starship Children's Hospital.

During the past decade, Starship Children's Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 36 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 15 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Starship Children's Hospital" #1 sponsor was "Children's Oncology Group" with 49 trials, followed by "National Cancer Institute (NCI)" with 17 trials sponsored, "Australian & New Zealand Children's Haematology/Oncology Group" with 1 trials sponsored, "LLS PedAL Initiative, LLC" with 1 trials sponsored and "The Hospital for Sick Children" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Starship Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 50 trials as a collaborator, "Children's Oncology Group" with 2 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator and "Cancer Trials Ireland" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Starship Children's Hospital" are "Acute Lymphoblastic Leukemia" (7 trials), "Adult Rhabdomyosarcoma" (5 trials), "Ganglioneuroblastoma" (5 trials), "Recurrent Neuroblastoma" (5 trials) and "Stage 4 Neuroblastoma" (5 trials). Many other conditions were trialed in "Starship Children's Hospital" in a lesser frequency.

Most popular intervention types in "Starship Children's Hospital" are "Drug" (54 trials), "Other" (48 trials), "Biological" (28 trials), "Radiation" (28 trials) and "Procedure" (24 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (33 trials), "Cyclophosphamide" (28 trials), "Etoposide" (23 trials), "Vincristine Sulfate" (22 trials) and "Doxorubicin Hydrochloride" (19 trials). Other intervention names were less common.

The vast majority of trials in "Starship Children's Hospital" are 71 trials for "All" genders.

Currently, there are NaN active trials in "Starship Children's Hospital". undefined are not yet recruiting, 14 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Starship Children's Hospital, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Starship Children's Hospital, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".